Growth hormone-releasing hormone receptor antagonists inhibit human gastric cancer through downregulation of PAK1-STAT3/NF-κB signaling.
Gan J, Ke X, Jiang J, Dong H, Yao Z, Lin Y, Lin W, Wu X, Yan S, Zhuang Y, Chu WK, Cai R, Zhang X, Cheung HS, Block NL, Pang CP, Schally AV, Zhang H.
Gan J, et al. Among authors: zhang x, zhang h.
Proc Natl Acad Sci U S A. 2016 Dec 20;113(51):14745-14750. doi: 10.1073/pnas.1618582114. Epub 2016 Dec 7.
Proc Natl Acad Sci U S A. 2016.
PMID: 27930339
Free PMC article.